日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia.

随机、双盲、安慰剂对照、交叉试验,研究口服多西环素治疗遗传性出血性毛细血管扩张症鼻出血的疗效

Thompson K P, Sykes J, Chandakkar P, Marambaud P, Vozoris N T, Marchuk D A, Faughnan M E

Predictors of mortality in patients with hereditary hemorrhagic telangiectasia

遗传性出血性毛细血管扩张症患者死亡率的预测因素

Thompson, K P; Nelson, J; Kim, H; Pawlikowska, L; Marchuk, D A; Lawton, M T; Faughnan, Marie E

Utility of modified Rankin Scale for brain vascular malformations in hereditary hemorrhagic telangiectasia

改良Rankin量表在遗传性出血性毛细血管扩张症脑血管畸形中的应用

Thompson, K P; Nelson, J; Kim, H; Weinsheimer, S M; Marchuk, D A; Lawton, M T; Krings, T; Faughnan, M E

Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus

慢性肾脏病中的高血压和蛋白尿定位于小鼠11号染色体上的一个基因位点

Salzler, H R; Griffiths, R; Ruiz, P; Chi, L; Frey, C; Marchuk, D A; Rockman, H A; Le, T H

Meta-analysis of age at onset in spastin-associated hereditary spastic paraplegia provides no evidence for a correlation with mutational class

对痉挛蛋白相关遗传性痉挛性截瘫发病年龄的荟萃分析未发现与突变类型相关的证据。

Yip, A G; Dürr, A; Marchuk, D A; Ashley-Koch, A; Hentati, A; Rubinsztein, D C; Reid, E

Pathogenesis of hemangioma

血管瘤的发病机制

Marchuk, D A

The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2

激活素受体样激酶1基因:遗传性出血性毛细血管扩张症2型中的基因组结构和突变

Berg, J N; Gallione, C J; Stenzel, T T; Johnson, D W; Allen, W P; Schwartz, C E; Jackson, C E; Porteous, M E; Marchuk, D A

A 90 kb DNA deletion associated with neurofibromatosis type 1

与1型神经纤维瘤病相关的90 kb DNA缺失

Upadhyaya, M; Cheryson, A; Broadhead, W; Fryer, A; Shaw, D J; Huson, S; Wallace, M R; Andersen, L B; Marchuk, D A; Viskochil, D